Cargando…
Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
The traditional classification of lung cancer into small cell lung cancer and non‐small cell lung cancer (NSCLC) has been transformed with the increased understanding of the molecular alterations and genomic biomarkers that drive the development of lung cancer. Increased activation of the phosphatid...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049515/ https://www.ncbi.nlm.nih.gov/pubmed/31989769 http://dx.doi.org/10.1111/1759-7714.13328 |